Canakinumab
Pharmaceutical drugMédicament
Canakinumab, sold under the brand name Ilaris, is a medication for the treatment of systemic juvenile idiopathic arthritis, active Still's disease, including adult-onset Still's disease, gout flares.Le canakinumab est un anticorps monoclonal dirigé contre l'interleukine 1 bêta.
